Krasney Karen 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Dec 16, 2024
Insider Transaction Report
Form 4
Krasney Karen
EVP, GENERAL COUNSEL
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-12-13−5,000→ 0 totalExercise: $1.39Exp: 2026-06-02→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2024-12-13$1.39/sh+8,000$11,120→ 28,047 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-13−3,000→ 0 totalExercise: $1.39Exp: 2025-03-03→ Common Stock (3,000 underlying)
Footnotes (4)
- [F1]This option was granted on March 3, 2015 and was previously covering 30,000 shares at an exercise price of $5.78 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F2]Shares vested 1/48th on the first day of each month commencing April 1, 2015.
- [F3]This option was granted on June 2, 2016 and was previously covering 50,000 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F4]Shares vested 1/48th on the first day of each month commencing July 1, 2016.